Showing 79,621 - 79,640 results of 79,698 for search '(( significantly linked decrease ) OR ( significantly ((related diseases) OR (greater decrease)) ))', query time: 1.40s Refine Results
  1. 79621

    Image1_Genomic study of TEX15 variants: prevalence and allelic heterogeneity in men with spermatogenic failure.JPEG by Sidra Qureshi (15442919)

    Published 2023
    “…Our findings support the notion of increased gene variant frequency in SPGF and its genetic and allelic heterogeneity as it relates to complex disease such as male infertility.…”
  2. 79622

    DataSheet_1_Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.pdf by Kathryn A. Mraz (15881621)

    Published 2023
    “…Most respondents (91%, 87/96) completed information regarding their demographics and practice characteristics relating to hereditary gastrointestinal cancer and chemoprevention clinical practices. …”
  3. 79623

    Table2_Genomic study of TEX15 variants: prevalence and allelic heterogeneity in men with spermatogenic failure.XLSX by Sidra Qureshi (15442919)

    Published 2023
    “…Our findings support the notion of increased gene variant frequency in SPGF and its genetic and allelic heterogeneity as it relates to complex disease such as male infertility.…”
  4. 79624

    Image3_Genomic study of TEX15 variants: prevalence and allelic heterogeneity in men with spermatogenic failure.png by Sidra Qureshi (15442919)

    Published 2023
    “…Our findings support the notion of increased gene variant frequency in SPGF and its genetic and allelic heterogeneity as it relates to complex disease such as male infertility.…”
  5. 79625

    Image4_Genomic study of TEX15 variants: prevalence and allelic heterogeneity in men with spermatogenic failure.JPEG by Sidra Qureshi (15442919)

    Published 2023
    “…Our findings support the notion of increased gene variant frequency in SPGF and its genetic and allelic heterogeneity as it relates to complex disease such as male infertility.…”
  6. 79626
  7. 79627

    Crash risk of ESC-fitted passenger cars by Tapio Koisaari (6622886)

    Published 2019
    “…The mileage-proportional crash rate of ESC-equipped cars was 64% (95% confidence interval, 61%; 67%) lower in run-off-road crashes resulting in injury and as much as 82% (65%; 91%) lower in fatal run-off-road crashes when suicides and disease attacks were not taken into account.</p> <p><b>Conclusions:</b> Our results show that modern passenger cars provide a significant crash risk reduction, which depends on both ESC and passive safety features introduced. …”
  8. 79628
  9. 79629

    Image_1_Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.tiff by Tejpal Gill (618904)

    Published 2022
    “…These bacteria were not identified by comparing their relative abundance alone. Predictive metagenomic analysis revealed perturbation of metabolites/metabolic pathways in axSpA patients. …”
  10. 79630

    Image_3_Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern.jpg by Chang-Kyu Heo (5467367)

    Published 2023
    “…Introduction<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. …”
  11. 79631

    Table_2_Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.docx by Tejpal Gill (618904)

    Published 2022
    “…These bacteria were not identified by comparing their relative abundance alone. Predictive metagenomic analysis revealed perturbation of metabolites/metabolic pathways in axSpA patients. …”
  12. 79632

    Image_3_Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.tiff by Tejpal Gill (618904)

    Published 2022
    “…These bacteria were not identified by comparing their relative abundance alone. Predictive metagenomic analysis revealed perturbation of metabolites/metabolic pathways in axSpA patients. …”
  13. 79633

    Image_1_ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma.TIFF by Michael Merker (5470025)

    Published 2020
    “…<p>High-risk rhabdomyosarcoma (RMS) occurring in childhood to young adulthood is associated with a poor prognosis; especially children above the age of 10 with advanced stage alveolar RMS still succumb to the disease within a median of 2 years. The advent of chimeric antigen receptor (CAR)-engineered T cells marked significant progress in the treatment of refractory B cell malignancies, but experience for solid tumors has proven challenging. …”
  14. 79634

    Image 1_Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.jpeg by Soo Chin Lee (8943938)

    Published 2025
    “…Experts reached 80%-90% consensus for using genetic risk assessment tools in low/under-resourced healthcare systems and considering patients with likely/pathogenic variants in BRCA for risk reduction surgery. Significant gaps existed between real-world practices and recommendations, particularly in offering pretest GC to patients with suspected hereditary BC and to blood relatives of patients with BRCA germline pathogenic variant BC, ideal time for GT, considering GT for early TNBC patients irrespective of age, offering post-test GC for positive results, utilising risk assessment tools, and streamlining GC through non-geneticist HCPs.…”
  15. 79635

    Table_1_A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report.docx by Mara Colombo (181275)

    Published 2023
    “…The potential combined effect of these variants on cancer risks is mostly unknown, posing a serious problem for genetic counseling in these individuals and their relatives, in whom the variants may segregate singly or in combination. …”
  16. 79636

    Table_1_Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern.docx by Chang-Kyu Heo (5467367)

    Published 2023
    “…Introduction<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. …”
  17. 79637

    Image_6_Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern.jpg by Chang-Kyu Heo (5467367)

    Published 2023
    “…Introduction<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. …”
  18. 79638

    Table 1_Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.docx by Soo Chin Lee (8943938)

    Published 2025
    “…Experts reached 80%-90% consensus for using genetic risk assessment tools in low/under-resourced healthcare systems and considering patients with likely/pathogenic variants in BRCA for risk reduction surgery. Significant gaps existed between real-world practices and recommendations, particularly in offering pretest GC to patients with suspected hereditary BC and to blood relatives of patients with BRCA germline pathogenic variant BC, ideal time for GT, considering GT for early TNBC patients irrespective of age, offering post-test GC for positive results, utilising risk assessment tools, and streamlining GC through non-geneticist HCPs.…”
  19. 79639

    Table_1_A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report.docx by Mara Colombo (181275)

    Published 2023
    “…The potential combined effect of these variants on cancer risks is mostly unknown, posing a serious problem for genetic counseling in these individuals and their relatives, in whom the variants may segregate singly or in combination. …”
  20. 79640

    Image_5_Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern.jpg by Chang-Kyu Heo (5467367)

    Published 2023
    “…Introduction<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. …”